Literature DB >> 21671181

Effect of sublingual immunotherapy on level of cytokines in PBMCs of patients with allergic asthma.

Zhongxi Wang1, Wenjing Li2, Huan Chen2, Wei Zhang2.   

Abstract

This study examined the possible mechanism of sublingual immunotherapy (SLIT) in the treatment of allergic asthma. Forty asthma patients allergic to dust mite were enrolled. They received SLIT with dermatophagoides farinae (Der. f) drops for one year. Thirty healthy subjects served as controls. The levels of IL-4 and IFN-γ of peripheral blood mononuclear cells (PBMCs) were determined in allergic asthma patients before and after the SLIT as well as the healthy subjects. The results showed that the level of IL-4 was substantially increased and that of IFN-γ remarkably decreased in the patients before the SLIT as compared with those in the healthy subjects (P<0.05). After the SLIT, the level of IL-4 was significantly reduced and that of IFN-γ elevated in these allergic asthma patients. It was concluded that sublingual immunotherapy is effective for patients with allergic asthma. And it may work by regulating the balance of Th1/Th2 through changing the expression of IL-4 and IFN-γ in PBMCs.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21671181     DOI: 10.1007/s11596-011-0384-5

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  7 in total

1.  Absence of systemic immunologic changes during dose build-up phase and early maintenance period in effective specific sublingual immunotherapy in children.

Authors:  E Dehlink; T Eiwegger; M Gerstmayr; E Kampl; B Bohle; K-W Chen; S Vrtala; R Urbanek; Z Szépfalusi
Journal:  Clin Exp Allergy       Date:  2006-01       Impact factor: 5.018

2.  A randomized controlled trial of sublingual immunotherapy for Japanese cedar pollinosis.

Authors:  Shigetoshi Horiguchi; Yoshitaka Okamoto; Syuji Yonekura; Toru Okawa; Heizaburou Yamamoto; Naoki Kunii; Daijyu Sakurai; Takashi Fujimura; Kazuyoshi Nakazawa; Hiroshi Yasueda
Journal:  Int Arch Allergy Immunol       Date:  2007-12-14       Impact factor: 2.749

3.  Serum IL-4 as a marker of immunological response to sublingual immunotherapy.

Authors:  G Ciprandi; M De Amici; G Murdaca; B M Colombo; S Quaglini; G Marseglia; M Di Gioacchino
Journal:  J Biol Regul Homeost Agents       Date:  2008 Apr-Jun       Impact factor: 1.711

4.  Lack of detectable alterations in immune responses during sublingual immunotherapy in children with seasonal allergic rhinoconjunctivitis to grass pollen.

Authors:  C Rolinck-Werninghaus; M Kopp; C Liebke; J Lange; U Wahn; B Niggemann
Journal:  Int Arch Allergy Immunol       Date:  2005-01-12       Impact factor: 2.749

5.  Allergen rush immunotherapy increases interleukin (IL)-12 production and IL-12 receptor beta2 chain expression in patients with allergic asthma.

Authors:  Toshiyuki Tazaki; Kenji Minoguchi; Takuya Yokoe; Naruhito Oda; Tadanori Hashimoto; Akihiko Tanaka; Shinji Okada; Yoshitaka Yamamoto; Yoshio Watanabe; Mitsuru Adachi
Journal:  Cell Immunol       Date:  2004-03       Impact factor: 4.868

6.  Sublingual immunotherapy with Dermatophagoides monomeric allergoid down-regulates allergen-specific immunoglobulin E and increases both interferon-gamma- and interleukin-10-production.

Authors:  L Cosmi; V Santarlasci; R Angeli; F Liotta; L Maggi; F Frosali; O Rossi; P Falagiani; G Riva; S Romagnani; F Annunziato; E Maggi
Journal:  Clin Exp Allergy       Date:  2006-03       Impact factor: 5.018

7.  Allergen-induced in vitro expression of IL-18, SLAM and GATA-3 mRNA in PBMC during sublingual immunotherapy.

Authors:  J Savolainen; K Nieminen; K Laaksonen; T Laiho; L Jacobsen; R Lahesmaa; E O Terho; E Valovirta
Journal:  Allergy       Date:  2007-08       Impact factor: 13.146

  7 in total
  4 in total

Review 1.  Chinese guideline on sublingual immunotherapy for allergic rhinitis and asthma.

Authors:  Huabin Li; Shi Chen; Lei Cheng; Yinshi Guo; He Lai; Yong Li; Xiaoping Lin; Zheng Liu; Qianhui Qiu; Jie Shao; Li Shi; Man Tian; Chengshuo Wang; Hongtian Wang; Xueyan Wang; Qingyu Wei; Yongxiang Wei; Li Xiang; Qintai Yang; Changqing Zhao; Huanping Zhang; Yuxiang Zhi; Junxiao Gao; Quansheng Li; Juan Liu; Kuiji Wang; Wencheng Zhou; Luo Zhang
Journal:  J Thorac Dis       Date:  2019-12       Impact factor: 2.895

2.  Morning Versus Evening Dosing of Sublingual Immunotherapy in Allergic Asthma: A Prospective Study.

Authors:  Feng Liao; Shi Chen; Ling Wang; Ying-Yu Quan; Li-Li Chen; Guo-Hua Lin
Journal:  Front Pediatr       Date:  2022-06-09       Impact factor: 3.569

3.  Sublingual immunotherapy for treating adult patients with allergic rhinitis induced by house dust mite among Chinese Han population: A retrospective study.

Authors:  Miao Han; Yan Chen; Mi Wang
Journal:  Medicine (Baltimore)       Date:  2018-07       Impact factor: 1.889

4.  Acupuncture as an add-on therapy to sublingual allergen-specific immunotherapy for patients with allergic rhinitis.

Authors:  Jiang-Hua Li; Lin-Hong Yang; Ying Chen; Zong-Xian Fan
Journal:  Medicine (Baltimore)       Date:  2019-01       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.